ISSN 2147-9720 | E-ISSN 2148-4279
Case Report
Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab
1 Department of Rheumatology, Şifa University Faculty of Medicine, İzmir, Turkey  
2 Department of Otolaryngnology, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey  
3 Department of Dermatology, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey  
Eur J Rheumatol 2014; 1: 167-169
DOI: 10.5152/eurjrheumatol.2014.140001
Key Words: Rheumatoid arthritis, candida laryngitis, adalimumab
Abstract

Rheumatoid arthritis is a chronic erosive rheumatic disease that can present with polyarticular involvement. Anti-TNF-alpha drugs are used in cases that are resistant to traditional disease-modifying antirheumatic drugs (DMARDs). Anti-TNF-alpha drugs are groundbreaking drugs, the efficacy of which has been proven in the treatment of rheumatoid arthritis. However, the data concerning safety remain limited and contradictory. The risk of tuberculosis reactivation, various infections, as well as lymphoproliferative disease and/or secondary malignancy is a matter of discussion. In this report, we report a 52-year-old male patient using adalimumab for active rheumatoid arthritis who presented to our polyclinic with generalized mouth and throat sores, hoarseness, and swallowing difficulty. Candida laryngitis was detected in the laryngoscopy and culture samples. Adalimumab was discontinued, and the infection was controlled with anti-fungal treatment.

 

Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 08.04.2019